The three-building facility enables JN to expand its ability to increase vaccine supplies. The move is intended to help reduce time to market for the company's Meningococcal meningitis serotypes A, C, Y and W-135.
Companies in this press-release
JN-Intl. acquires vaccine facilities from Pfizer
Biopharmaceutical firm JN Intl.acquired Biocor, a subsidiary of Pfizer, Inc.
Jun 2, 2009
Recommended
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Downloads
